• MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Neurology Live. All rights reserved.

Optimal Management of Relapsing Multiple Sclerosis: Advanced Practice Providers Perspectives

Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.

EP. 1: Revised Recommendations for Diagnosing Relapsing MS

August 20th 2021

An overview of revisions to the McDonald criteria used to help diagnose relapsing multiple sclerosis, and recommendations to follow when referring to criteria and imaging results when evaluating patients.

EP. 2: Tailoring Therapy for Patients With Relapsing MS

August 20th 2021

Important insight related to individualized treatment approaches for patients with relapsing multiple sclerosis.

EP. 3: Overcoming Treatment Challenges in Relapsing MS

August 26th 2021

The rationale for early treatment of multiple sclerosis, and an overview of limitations that impact the management of relapsing multiple sclerosis.

EP. 4: Interferons and Glatiramer Acetate for Relapsing MS

August 26th 2021

Health care professionals who work in the field of neurology comment on their experience using interferon therapies and glatiramer acetate as treatment for relapsing multiple sclerosis.

EP. 5: Cladribine Treatment for Relapsing MS

September 3rd 2021

An overview of clinical trial data supporting the use of cladribine as treatment for relapsing multiple sclerosis (MS).

EP. 6: Risk of Relapse/Progression in MS

September 3rd 2021

A discussion on the integration of newer therapies, like cladribine, into the treatment landscape for relapsing multiple sclerosis (MS), and insight regarding what is currently understood about risks of disease progression and relapse.

EP. 7: Clinical Experience Treating Relapsing MS With Cladribine

September 10th 2021

Best practices for treating patients with relapsing multiple sclerosis (MS) with cladribine, based on data revealed by clinical trials and experience in real-world practice.

EP. 8: S1P1 Receptor Modulators for Relapsing MS

September 10th 2021

Bryan Walker, MHS, PA-C, describes the rationale for treating relapsing multiple sclerosis (MS) with sphingosine 1-phosphate (S1P1) receptor modulators and compares available options.

EP. 9: Selecting an S1P Modulator for Relapsing MS

September 17th 2021

Variables that impact which S1P receptor modulator is selected as treatment for relapsing multiple sclerosis.

EP. 10: Anti-CD20 Therapies for Relapsing MS

September 17th 2021

An overview of clinical trial data supporting the use of ocrelizumab and ofatumumab as treatment options for patients with relapsing multiple sclerosis.